Indian company to invest $50 million in Namangan region projects

According to the press service of the regional administration, these projects, focusing on the pharmaceutical and diagnostic sectors, are scheduled for implementation between 2026 and 2028.

On March 1, representatives from Krsnaa Diagnostics visited several medical institutions across Namangan region to assess existing conditions and healthcare infrastructure. This visit was followed by a high-level meeting involving a delegation led by the Chairman of the Board of Krsnaa Diagnostics, Rajendra Mutha.

The governor of Namangan region, Shavkat Abdurazakov, held extensive discussions with the visiting guests regarding the foreign company’s capabilities and potential avenues for bilateral cooperation. The talks focused on how the company’s expertise in diagnostics could be integrated into the local healthcare system.

Following the successful negotiations, the Namangan regional administration and Krsnaa Diagnostics Ltd signed a Memorandum of Understanding (MoU) to collaborate on investment projects totaling $50 million. The regional administration noted that this memorandum signifies the commitment of both parties to develop and expand investment, industrial, and technological cooperation in the region.